NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and biotechnology company focused on developing and commercializing white label...
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...
NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label...
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing...
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of...
NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.96 | -43.5555555556 | 4.5 | 5.14 | 2.23 | 402810 | 3.79432035 | CS |
4 | 0.92 | 56.7901234568 | 1.62 | 5.5 | 1.42 | 1002157 | 3.82971606 | CS |
12 | -1.46 | -36.5 | 4 | 5.5 | 1.42 | 583931 | 3.76092875 | CS |
26 | -1.46 | -36.5 | 4 | 5.5 | 1.42 | 583931 | 3.76092875 | CS |
52 | -1.46 | -36.5 | 4 | 5.5 | 1.42 | 583931 | 3.76092875 | CS |
156 | -1.46 | -36.5 | 4 | 5.5 | 1.42 | 583931 | 3.76092875 | CS |
260 | -1.46 | -36.5 | 4 | 5.5 | 1.42 | 583931 | 3.76092875 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約